The Evolving Role of the Multiple Sclerosis Nurse - Implications of Future Management Directions

  title={The Evolving Role of the Multiple Sclerosis Nurse - Implications of Future Management Directions},
  author={C. Chrysovitsanou and Del Thomas and M. Duddy},
  journal={European neurological review},
The role of the multiple sclerosis (MS) nurse is constantly evolving, owing to the introduction of new MS therapies and new patient treatment and support strategies. The second MS nurse symposium, ‘The Evolving Role of the MS Nurse: Implications of Future Management Directions’ took place in Athens between 22–24 September 2011 and was attended by approximately 300 participants from 30 countries. Presentations at the symposium outlined the mechanisms of action and clinical evidence for novel… Expand
1 Citations

Figures and Tables from this paper

Identification of clinician challenges in order to drive the development of competency-based education: results from an international needs assessment in multiple sclerosis
Objective. To highlight clinical gaps of neurologists and nurses regarding their skills and confidence in engaging and communicating with multiple sclerosis (MS) patients to inform the design ofExpand


Factors that influence adherence with disease-modifying therapy in MS
This study characterizes factors that are associated with failure to fully adhere with disease modifying injection therapy for MS and underscores the principles associated with optimizing adherence and its implications for effective treatment of the disease process in MS. Expand
Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.
Costs of MS patients in Canada are higher today than shown in previous studies, and disease progression and relapses are associated with increased economic and quality of life burden. Expand
Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis — Results of the BetaPlus observational cohort study
The study showed that the usage of autoinjector devices chosen during the study was the strongest predictor of drug adherence of all the supportive elements tested in this study. Expand
Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review.
Data show that the IMAs have similar effects on several physical and inflammatory measures and Avonex has demonstrated efficacy in slowing cognitive progression in relapsing MS. Expand
Internet Usage by Patients with Multiple Sclerosis: Implications to Participatory Medicine and Personalized Healthcare
It is suggested that MS patients benefit from online information, and it emphasizes the importance of resources tailored to patients needs. Expand
Multiple Sclerosis Patients' Interest in and Likelihood of Using Online Health-Care Services
Although the vast majority of patients were satisfied with the frequency of their clinic visits, patients who called the clinic more frequently reported lower satisfaction, and their likelihood of using online health-care services was lower. Expand
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
The use of administrative data to develop case definitions and further define the epidemiology of MS in Manitoba is supported, suggesting the rising prevalence with minimally changing incidence suggests improving survival. Expand
[Practical advice for a safe, effective and well tolerated therapy of multiple sclerosis].
The dosage of interferon-beta preparations should be gradually increased during the first weeks of therapy to ameliorate flu-like adverse effects and effective contraception must be used, in particular with mitoxantrone and azathioprine. Expand
Understanding and meeting injection device needs in multiple sclerosis: a survey of patient attitudes and practices
The combination of a reliable and flexible autoinjection device with dose-monitoring technology may improve communication between health care professionals and patients, and improve treatment adherence, in patients with relapsing multiple sclerosis. Expand
Prevalence of Multiple Sclerosis in Canada: A Systematic Review
  • A. Poppe, C. Wolfson, B. Zhu
  • Geography, Medicine
  • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  • 2008
This review confirms Canada as a country of very high MS prevalence and it is the first study to demonstrate that variation in regional estimates represents true differences in prevalence within Canada. Expand